Although IL-13 clearly plays an important role in the schistosomiasis model, it remains unclear to what extent targeting this pathway might be useful in the treatment of other fibroproliferative diseases. Therefore, we are investigating the role of Th2-type cytokines in several models of fibrosis that affect the lung, liver, and intestine to determine whether there are common as well as distinct mechanisms of fibrosis in various organ systems and/or diseases. The models that were set up in the lab over the past few years include a mouse model of chronic asthma, several chronic models of inflammatory bowel disease, and a model of obesity induced steatosis. Projects completed during the past year: Two new comprehensive reviews on fibrosis were completed in the previous year. These reviews appeared in Annual Reviews of Pathology: Mechanisms of Disease and Biochim Biophys Acta. Active projects: 1. Transgenic and knockout mice are being used to explore the mechanisms of fibrosis in models of DSS and TNBS-induced colitis 2. Studies are underway to explore the role of IL-13Ra2 blockade in models of fibrosis and chronic IBD. 3. Studies are underway to better understand the role of the immune system in the development of non-alcoholic fatty liver disease (NAFLD).

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
Sun, Rex; Urban Jr, Joseph F; Notari, Luigi et al. (2016) Interleukin-13 Receptor α1-Dependent Responses in the Intestine Are Critical to Parasite Clearance. Infect Immun 84:1032-44
Wynn, Thomas A; Vannella, Kevin M (2016) Macrophages in Tissue Repair, Regeneration, and Fibrosis. Immunity 44:450-62
Woytschak, Janine; Keller, Nadia; Krieg, Carsten et al. (2016) Type 2 Interleukin-4 Receptor Signaling in Neutrophils Antagonizes Their Expansion and Migration during Infection and Inflammation. Immunity 45:172-84
Vannella, Kevin M; Ramalingam, Thirumalai R; Hart, Kevin M et al. (2016) Acidic chitinase primes the protective immune response to gastrointestinal nematodes. Nat Immunol 17:538-44
Vannella, Kevin M; Ramalingam, Thirumalai R; Borthwick, Lee A et al. (2016) Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis. Sci Transl Med 8:337ra65
Evans, Christopher M; Raclawska, Dorota S; Ttofali, Fani et al. (2015) The polymeric mucin Muc5ac is required for allergic airway hyperreactivity. Nat Commun 6:6281
Wang, An-Jiang; Yang, Zhonghan; Grinchuk, Viktoriya et al. (2015) IL-25 or IL-17E Protects against High-Fat Diet-Induced Hepatic Steatosis in Mice Dependent upon IL-13 Activation of STAT6. J Immunol 195:4771-80
Badalyan, Vahe; Thompson, Robert; Addo, Kezia et al. (2014) TNF-α/IL-17 synergy inhibits IL-13 bioactivity via IL-13Rα2 induction. J Allergy Clin Immunol 134:975-8.e5
Suwara, M I; Green, N J; Borthwick, L A et al. (2014) IL-1* released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol 7:684-93
Blackwell, Timothy S; Tager, Andrew M; Borok, Zea et al. (2014) Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med 189:214-22

Showing the most recent 10 out of 28 publications